Integrating Novel Metabolomics Biomarkers with Multi‐modal Risk Factors in Predicting Mild Cognitive Impairment and Alzheimer's Disease

Abstract

Background: Recent research approaches to an expanding collection of well‐characterized databases have examined varying arrays of biomarkers and risk factors related to Alzheimer's disease (AD).